Sanofi Ranks Third on the Access to Medicine Foundation’s 2012 ATM Index

PR Newswire/Les Echos/ 
Sanofi Ranks Third on the Access to Medicine Foundation's 2012 ATM Index 
Paris, France - November 28, 2012 - Sanofi (EURONEXT: SAN and NYSE: SNY)
announced today that it ranked third among twenty pharmaceutical companies on
the 2012 Access to Medicine Index (ATM Index) created by the Access to Medicine
Foundation, an international non-profit organization dedicated to improving
access to medicine to societies in need. 
"This third ranking on the 2012 Access to Medicine Index is a recognition of
Sanofi's efforts to act with all our partners to protect health and raise the
hopes of patients," said Gilles Lhernould, Senior Vice President, Corporate
Social Responsibility, Sanofi. "The key challenge in the future will be to
eliminate the north-south divide in access to health care. As a global health
care leader, we are the right partner to achieve this goal." 
The Access to Medicine Foundation particularly welcomes the initiatives of
Sanofi in the fields of multi-resistant bacterial infections, malaria,
tuberculosis and Neglected Tropical Diseases, as well as the renewal of its
partnership with the World Health Organization to fight those diseases,
including Buruli ulcer, Human African trypanosomiasis (sleeping sickness),
Chagas disease and leishmaniasis. 
In its report, the Access to Medicine Foundation, creator of the ATM 2012 Index,
highlights that Sanofi has significantly improved its approach to access to
medicine in several areas and it leads the field in the area of public policy.
It has continued to invest in research and development, targeting relevant
diseases, and has a broad range of molecules in its pipeline. The company has
robust access management systems, inter- and intra-country tiered pricing, works
with local governments to improve capability advancement and has initiatives in
both donations and sustainable philanthropy, with two single-drug donation
The goal of the Access to Medicine Index is to supply pharmaceutical companies,
investors, governments, academics, nongovernmental organizations and the general
public with independent, impartial and reliable information on individual
pharmaceutical companies' efforts to improve global access to medicine. The
Access to Medicine Foundation strives to provide companies with a transparent
means by which pharmaceutical companies assess, monitor and improve their own
performance and their public and investment profiles while building a platform
on which all stakeholders can share best practices in the area of global access
to medicine 
About Sanofi Access to Medicines
About Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients' needs. Sanofi has core
strengths in the field of healthcare with seven growth platforms: diabetes
solutions, human vaccines, innovative drugs, consumer healthcare, emerging
markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT:
SAN) and in New York (NYSE: SNY). 
Sanofi Media Relations
Frédéric Lemonde-San
Tel: +33 (0) 1 53 77 91 55
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication. 
-0- Nov/28/2012 07:57 GMT
Press spacebar to pause and continue. Press esc to stop.